Main > ONCOLOGY (**) > Leukemia>Myeloid>Chronic>Ph+ * > Treatment > Co.: USA. P. Brand Bosutinib ** > (*) USA Approval Date: 2012. 09.04>

---

with accelerated or blast phase Ph+ CML with resistance or intolerance to prior therapy.


(*) USA Approval Date: 2012. 09.04>'s products
This section has no products